Active substanceZinc oxideZinc oxide
Similar drugsTo uncover
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
  • Tsindol
    suspension externally 
    YUZHFARM, LLC     Russia
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Zinc ointment
    ointment externally 
    SAMARAHEDPROM, JSC     Russia
  • Zinc ointment
    ointment externally 
  • Zinc ointment
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Zinc ointment
    ointment externally 
  • Zinc paste
    paste externally 
  • Zinc paste
    paste externally 
  • Zinc paste
    paste externally 
  • Dosage form: & nbsp

    suspension for external use.

    Composition:

    Composition per 100 g.

    Active substance: zinc oxide 12.5 g

    Excipients: talcum medical - 12,5 g, potato starch - 12,5 g, glycerol - 20 g, ethanol 70% - 20 g, purified water - up to 100 g.

    Description:

    Inhomogeneous suspension with a rapidly precipitated white or white precipitate after shaking, with a grayish hue of color.

    Pharmacotherapeutic group:Dermatoprotective agent.
    ATX: & nbsp

    A.12.C.B   Zinc Preparations

    Pharmacodynamics:Antiseptic, astringent, drying agent. Reduces exudation and mocclusion, which removes local inflammation and irritation. The symptomatic effect of the drug is determined by zinc oxide.
    Indications:

    Dermatitis, skin ulcers, intertrigo.

    Contraindications:

    Hypersensitivity to the components of the drug.

    Pregnancy and lactation:

    Possible use during pregnancy and during breastfeeding.

    Dosing and Administration:

    Outwardly. Shake before use. A tampon moistened with the drug, put a suspension on the affected skin 2-3 times a day.

    Side effects:

    Possible local allergic reactions: itching, hyperemia, rash.

    Overdose:

    Cases of overdose with external application are not described.

    Interaction:

    Not described.

    Special instructions:

    Avoid contact with eyes.

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (transport management, work with moving mechanisms).

    Form release / dosage:

    Suspension for external use 12,5%.

    Packaging:

    For 100 g or 125 g of the drug in bottles of dark glass with a screw mouth, sealed with polyethylene plugs and caps screwed.

    Each bottle, together with the instructions for use, is placed in a pack of cardboard. It is allowed to pack vials with an equal number of instructions for use in group packaging.

    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years. Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002120
    Date of registration:02.07.2013
    The owner of the registration certificate:TULA PHARMACEUTICAL FACTORY, LTD. TULA PHARMACEUTICAL FACTORY, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp09.10.2015
    Illustrated instructions
      Instructions
      Up